DOUGLAS RICHARD
SEC CIK 1021015 · EDGAR
BoughtSold
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
| 13 | DOUGLAS RICHARD | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:56 | 2026-06-20 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | — | +18.9K | 73.2K | +35% | — |
| D | 2026-06-22 16:26 | 2026-06-17 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | A - Grant | $0.00 | +30.4K | 261.0K | +13% | $0 |
| 2026-03-20 | 2026-03-19 | ALDX | Aldeyra Therapeutics, Inc. | DOUGLAS RICHARD | Dir | P - Purchase | $1.40 | +70.0K | 195.0K | +56% | +$98.0K | |
| 2025-08-13 | 2025-08-13 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | P - Purchase | $1.39 | +80.0K | 230.6K | +53% | +$111.2K | |
| D | 2025-06-23 | 2025-06-18 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | A - Grant | $0.00 | +29.2K | 150.6K | +24% | $0 |
| D | 2025-06-13 | 2025-06-12 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | $0.00 | +10.4K | 54.3K | +24% | $0 |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | $0.00 | +6,670 | 43.9K | +18% | $0 |
| D | 2024-06-13 | 2024-06-11 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | A - Grant | $0.00 | +21.4K | 121.4K | +21% | $0 |
| D | 2023-06-13 | 2023-06-10 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | — | +3,100 | 37.2K | +9% | — |
| 2023-03-30 | 2023-03-29 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | P - Purchase | $4.32 | +80.0K | 100.0K | +400% | +$345.6K | |
| D | 2022-06-21 | 2022-06-17 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | — | +700 | 34.1K | +2% | — |
| D | 2021-12-15 | 2021-12-13 | NVAX | NOVAVAX INC | DOUGLAS RICHARD | Dir | M - OptEx | $25.60 | +1,500 | 33.5K | +5% | +$38.4K |
| 2021-11-23 | 2021-11-22 | MXCT | MAXCYTE, INC. | DOUGLAS RICHARD | Dir | P - Purchase | $11.12 | +20.0K | 20.0K | New | +$222.4K |
Purchase Sale Sale after option exercise All abbreviations